Sridhar Nimmagadda retweetledi
The new labeling agent could help us monitor differences in checkpoint expression across the body and allow oncologists to compare the performance of different antibody therapies. bit.ly/3kNTqND 2/3
English
Sridhar Nimmagadda
303 posts
Sridhar Nimmagadda
@Imaging4Health
Hopkins, Otterbein, Baltimore Katılım Mart 2016
87 Takip Edilen101 Takipçiler
Sridhar Nimmagadda retweetledi
We show that PD-L1 imaging agents can be used as a common denominator to compare the activity of different antibodies. This will allow us to compare the efficacy of different antibodies early in therapy, identify better drugs and optimize the doses. bit.ly/3kNTqND 3/3
English
Sridhar Nimmagadda retweetledi
Collecting biopsies isn't easy for patients who have multiple #Cancers. So, @HopkinsMedicine researchers developed an agent that marks so-called immune checkpoints in the whole body non-invasively for imaging. 1/3
bit.ly/3kNTqND
English
Sridhar Nimmagadda retweetledi
Congratulations to Jason Lewis, Ph.D. and Martin Pomper, Ph.D.!
Dr. Lewis and Dr. Pomper will receive our highest honor, the Gold Medal Award for Outstanding Contributions to Molecular Imaging at #WMIC2021.
We hope to see you there!
Register here: ow.ly/hBGq50GhrpR
English
Sridhar Nimmagadda retweetledi
Nice work by Dr. Sridhar Nimmagadda & colleagues @Imaging4Health We now have an exciting study of a novel PD-L1 PET tracer (developed by Dr. Nimmagadda in his lab at Johns Hopkins) open for pts starting pembrolizumab for lung cancer @HopkinsThoracic @hopkinskimmel #LCSM
Johns Hopkins Thoracic Oncology@HopkinsThoracic
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics | PNAS pnas.org/content/118/37…
English
English
You are too nice @michael_gorin! #youarepromotedsoontoo Would not be where I am without you! #molecularimaging
Michael Gorin, M.D.@michael_gorin
Tweeting to congratulate my research partner and great friend Steve Rowe (@HopkinsNucs) on his promotion to Associate Professor!! Super proud!! @HopkinsMedicine @Hopkins_Rad @bradyurology
Jacksonville, MD 🇺🇸 English
@PeterCaravan @harvardmed @MGHImaging @AcadiaU @UBC @MGHMartinos Congratulations @PeterCaravan what a great a way to start a new year!
English
Honored to become Prof of Radiology @harvardmed @MGHImaging Long trek enabled by great collaborators and mentees, support from MGH, and a long list of great mentors from @AcadiaU, @UBC, Epix Med, and @MGHMartinos Thanks to all!
English
@deniswirtz @JohnsHopkins @HopkinsEngineer @hopkinskimmel @PSOC_JHU @JHU_ChemBE @JHUPath @NCIPhySci @theNCI @theNAEng @theNAMedicine Congratulations @deniswirtz
English
I just learned I have been elected to the Royal Academy of Medicine of Belgium.
Apparently it’s a first for a non-MD and an engineer.
I feel much humbled by this honor and recognize the immense contributions of my students, fellows and colleagues @JohnsHopkins and elsewhere.
English
Sridhar Nimmagadda retweetledi
Dr. Martin Pomper Past-President of WMIS delivered a compelling Plenary at ESNM today where he showed his Journey imaging PSMA starting in 1997. He stated PSMA imaging is leading us in the direction of a paradigm shift and a path to cure with imaging.
English
Congratulations Jason! A fantastic recognition to everything that you do.
@Acadrad@AcadRad
Congratulations to this week's, and our first, @AcadRad #ImagingInnovator! We are so pleased to announce @LewisLabMSKCC has recently been awarded an @NCIMedia Outstanding Investigator (R35) Award. TY to Dr. Lewis for all of your hard work and your contributions to this community!
English
Sridhar Nimmagadda retweetledi
The first woman to be awarded a #NobelPrize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories - Marie Skłodowska Curie.
English
This is needed! A great team to learn from
Sridhar Nimmagadda@Imaging4Health
Registration for our workshop @Hopkins_Rad @HopkinsMedicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open! Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits. hopkinscme.cloud-cme.com/default.aspx?P… RTs are appreciated.
English
@GElegans1 We are excited to have you, Thank you Assaf.
English
Honored to speak in the workshop orgenized by @Imaging4Health. Really impressive list of instructors
Sridhar Nimmagadda@Imaging4Health
Registration for our workshop @Hopkins_Rad @HopkinsMedicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open! Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits. hopkinscme.cloud-cme.com/default.aspx?P… RTs are appreciated.
English
Registration for our workshop @Hopkins_Rad
@HopkinsMedicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open!
Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits.
hopkinscme.cloud-cme.com/default.aspx?P…
RTs are appreciated.
English
Sridhar Nimmagadda retweetledi
2019 Medicine Laureates William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza have identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.
#NobelPrize
English
Sridhar Nimmagadda retweetledi
Congratulations to Dr Gregg Semenza from @HopkinsMedicine on being awarded the 2019 @NobelPrize in Physiology or Medicine for work focused on how cells detect and respond to oxygen. He shares the honor with Dr William Kaelin and Sir Peter Ratcliffe.
hub.jhu.edu/2019/10/07/gre…
English
Sridhar Nimmagadda retweetledi
Come and join our team! #PhD opportunity on @FindAPhD: We are looking for a talented student interested in understanding how #cancer cells respond to #DNAdamage. We can even visualise this process in vivo! Details here:
findaphd.com/search/Project…. Pls get in touch. RTs appreciated
English
Transformative work Mikhail and team. Congratulations!!!
Mikhail Shapiro (same on bsky)@mikhailshapiro
Ultrasound imaging of gene expression in mammalian cells. Congratulations @farhadi_arash, Gabrielle Ho, @dannypsawyer, Ray Bourdeau and everyone who helped with this project. Thanks @sciencemagazine for publishing this work and for this highlight: sciencemag.org/news/2019/09/u…
English
Sridhar Nimmagadda retweetledi
With a 5-year min follow-up, the combination of nivolumab plus ipilimumab associated with 5-year survival of 52% in patients with metastatic #melanoma, compared with 44% for nivolumab alone and 26% for ipilimumab alone. See the CheckMate 067 trial. #ESMO19 nej.md/2mKBiso
English
We are thrilled to have @SimonRCherry at @Hopkins_Rad and exited to learn more about @TotalBodyPET project!
English